Bioactive potential of Auricularia cornea: Cytotoxicity, antioxidant activity, and beta-glucan content of mycelium and fruiting bodies
Keywords:
Bioactivity, good health, Jelly mushroom, Mushroom extracts, PolysaccharideAbstract
Auricularia cornea, an underexplored species within the medicinal Auricularia genus, was investigated for its bioactive potential, including cytotoxicity, antioxidant activity, and β-glucan content, promoting good health and well-being through natural nutraceuticals. This study compared three A. cornea isolates (MFLUCC 23-0084, MFLUCC 18-0346, and MFLUCC 18-0347) with commercial Auricularia spp. to evaluate their therapeutic and functional food applications. The methanolic extracts of mycelium were analyzed for free radical scavenging (DPPH assay), cytotoxicity against lung cancer cells (A549) and normal cells (Raw 264.7). β-Glucan content from fruiting bodies was also quantified by exploring sustainable fungal cultivation for high-value bioactive compounds. The results revealed strain-specific bioactivity: MFLUCC 23-0084 exhibited the highest antioxidant (IC50 5,530 ± 1,039 µg/mL), while MFLUCC 18-0346 showed low cytotoxicity against A549 cells (IC50 367.27 μg/mL). β-Glucan content varied significantly, with lab-cultivated isolates (12.14–13.22%) yielding less than A. auricula (18.86–24.94%). Low cytotoxicity to normal cells (IC50 >500 μg/mL) and moderate bioactivity suggest A. cornea’s suitability for functional foods, though strain optimization or extraction enhancements may be needed to rival leading species. This study positions A. cornea as a candidate for further development in sustainable nutraceuticals, through antioxidant applications and evaluating cultivation practices for enhanced β-glucan production.
References
Bandara AR, Karunarathna SC, Mortimer PE, Hyde KD, et al. 2019 – A review of the polysaccharide, protein and selected nutrient content of Auricularia, and their potential pharmacological value. Mycosphere 10(1), 579–607.
Fotakis G, Timbrell JA. 2006 – In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT, and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicology Letters 160(2), 171–177.
Kalitukha L, Bleha R, Synytsya A, Kraska J, Sari M. 2023 – Hydrocolloids from the mushroom Auricularia heimuer: Composition and properties. Journal of Fungi 9(6), 681.
Kim HY, Kim JH, Yang SB, Hong SG, et al. 2021 – Structural differences in β-glucans dictate their antitumor effects in human lung cancer cells. Carbohydrate Polymers 251, 117058.
Ma L, Chen H, Dong P, Lu X. 2013 – Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus. Food Chemistry 139(1–4), 503–508.
Megazyme© International Ireland Ltd. 2013 – Mushroom and yeast beta-glucan assay procedure booklet. K-YBGL 09/13. Wicklow, Ireland.
Mosmann T. 1983 – Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65(1–2), 55–63.
Phonemany M, Sysouphanthong P, Rujanapun N, Sarker SD, et al. 2025 – Identification and therapeutic efficacy of Pleurotus djamor var fuscopruinosus. Scientific Reports 15(1), 18929.
Prior RL, Wu X, Schaich K. 2005 – Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. Journal of Agricultural and Food Chemistry 53(10), 4290–4302.
Sari M, Prange A, Lelley JI, Hambitzer R. 2017 – Screening of beta-glucan contents in commercially cultivated and wild growing mushrooms. Food Chemistry 216, 45–51.
Setyawan RH, Ardiansyah A, Solihat NN, Elfirta RR, et al. 2024 – Chemical structure characterization of edible mushroom-extracted beta-glucan and its bioactivity. Bioactive Carbohydrates and Dietary Fibre 31, 100411.
Vaithanomsat P, Sukatta1 U, Choeyklin R, Boonpratuang T, et al. 2019 – Extraction of fungal mycelium beta-glucan: a source for immunomodulator. International Journal of Science and Innovative Technology 2(1), 18–25.
Vetvicka V, Vannucci L, Sima P, Richter J. 2019 – Beta-glucan: Supplement or drug? From laboratory to clinical trials. Molecules 24(7), 1251.
Volman JJ, Ramakers JD, Plat J. 2010 – Dietary modulation of immune function by β-glucans. Physiology & Behavior 94(2), 276–-284.
Wasser SP. 2017 – Medicinal mushrooms in human clinical studies. Part I. Anticancer, oncoimmunological, and immunomodulatory activities. International Journal of Medicinal Mushrooms 19(4), 279–317.
Xiao X, Ren W, Zhang N, Bing T, et al. 2019 – Comparative study of the chemical constituents and bioactivities of the extracts from fruits, leaves and root barks of Lycium barbarum. Molecules 24(8), 1585.
Xu S, Ping Z, Xu X, Zhang L. 2016 – Changes in shape and size of the stiff branched β-glucan in dimethylsulfoxide/water solutions. Carbohydrate Polymers 138, 86–93.
Zhang Y, Zeng Y, Men Y, Zhang J. 2018 – Structural characterization and immunomodulatory activity of exopolysaccharides from submerged culture of Auricularia auricula-judae. International Journal of Biological Macromolecules 115, 978–984.
